Melissa Teotico Triebell

Melissa Teotico Triebell, RAC, CCRC, is an accomplished professional with extensive experience in clinical and regulatory affairs across various companies in the biotechnology and healthcare sectors. As the Executive Director of Portfolio & Programs Management at Biosplice Therapeutics since May 2017, Melissa leads the development of innovative therapeutics based on alternative pre-mRNA splicing. Prior roles include Senior Consultant at snapIoT and Vice President of Clinical Solutions at Parallel 6, where Melissa contributed to creating mobile clinical platforms for patient engagement. Additionally, Melissa served as a Board Director for the Laboratory Robotics Interest Group and has held significant regulatory positions at True Diagnostics, Iris Molecular Diagnostics, Accriva Diagnostics, and GenVault Corporation. Melissa earned a BA in Animal Physiology from UC San Diego.